...
首页> 外文期刊>Der Pharma Chemica: journal for medicinal chemistry, pharmaceutical chemistry and computational chemistry >Synthesis of 2-(4-aryl(adamantyl)-2-phenyl??m??noth??azol-3-yl)-ethanol derivatives and prediction of their biological activity
【24h】

Synthesis of 2-(4-aryl(adamantyl)-2-phenyl??m??noth??azol-3-yl)-ethanol derivatives and prediction of their biological activity

机译:2-(4-芳基(金刚烷基)-2-苯基?? m ??无?? azol-3-基)-乙醇衍生物的合成及其生物学活性预测

获取原文
           

摘要

The synthesis of new 2-(4-aryl(adamantyl)-2-phenyl??m??noth??azol-3-yl)-ethanol derivatives has been carried out. The structures and purity of synthesized compounds were verified on the basis of elemental analysis, 1D? NMRspectroscopy and chromatography-mass spectrometry. To optimize the pharmacological screening of 2-(4- aryl(adamantyl)-2-phenyl??m??noth??azol-3-yl)-ethanol derivatives «drug-like» parameters have been calculated and simulation of biological properties has been done. It was established that 13 synthesized compounds comply with Lipinski's Rule of Five and can be recommended for experimental biological tests. Based on data PASS-prediction as priority directions for experimental trials screening for anti-ischemic and anti-inflammatory activity has been chosen. The most perspective substances for experimental biological tests were elected.
机译:已进行了新的2-(4-芳基(金刚烷基)-2-苯基?? m ??无??氮唑-3-基)-乙醇衍生物的合成。在元素分析的基础上验证了合成化合物的结构和纯度,1D? NMR光谱法和色谱-质谱法。为优化2-(4-芳基(金刚烷基)-2-苯基?? m ??无????? azol-3-基)-乙醇衍生物的药理筛选,已计算出“类药物”参数并模拟了生物学性质已经完成。已确定13种合成化合物符合Lipinski的5条规则,可以推荐用于实验生物学测试。基于数据,通过PASS预测作为筛选抗缺血和抗炎活性的实验试验的优先方向。选择了用于实验生物学测试的最有前景的物质。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号